Gene · 2822
Papers4,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases. | Clin Proteomics | 2022 | 35317720 | PubTator, text mining | PubMed |
| Exerkines in health, resilience and disease. | Nat Rev Endocrinol | 2022 | 35304603 | PubTator, text mining | PubMed |
| Prion-like domains drive CIZ1 assembly formation at the inactive X chromosome. | J Cell Biol | 2022 | 35289833 | PubTator, text mining | PubMed |
| Phosphatidic acid suppresses autophagy through competitive inhibition by binding GAPC (glyceraldehyde-3-phosphate dehydrogenase) and PGK (phosphoglycerate kinase) proteins. | Autophagy | 2022 | 35289711 | PubTator, text mining | PubMed |
| Controlling the Gate: The Functions of the Cytoskeleton in Stomatal Movement. | Front Plant Sci | 2022 | 35283892 | PubTator, text mining | PubMed |
| The role of lipid second messengers in aldosterone synthesis and secretion. | J Lipid Res | 2022 | 35278411 | PubTator, text mining | PubMed |
| HDL quality features revealed by proteome‒lipidome connectivity are associated with atherosclerotic disease. | J Mol Cell Biol | 2022 | 35278086 | PubTator, text mining | PubMed |
| Click chemistry and optogenetic approaches to visualize and manipulate phosphatidic acid signaling. | J Biol Chem | 2022 | 35276134 | PubTator, text mining | PubMed |
| Dynamics of T-Cell Intracellular Antigen 1-Dependent Stress Granules in Proteostasis and Welander Distal Myopathy under Oxidative Stress. | Cells | 2022 | 35269506 | PubTator, text mining | PubMed |
| T Lymphocyte and CAR-T Cell-Derived Extracellular Vesicles and Their Applications in Cancer Therapy. | Cells | 2022 | 35269412 | PubTator, text mining | PubMed |
| GenRisk: a tool for comprehensive genetic risk modeling. | Bioinformatics | 2022 | 35266528 | PubTator, text mining | PubMed |
| RNA-seq and integrated network analysis reveals the hub genes and key pathway of paclitaxel inhibition on Adriamycin resistant diffuse large B cell lymphoma cells. | Bioengineered | 2022 | 35263200 | PubTator, text mining | PubMed |
| Durable Effect of Pyrotinib and Metronomic Vinorelbine in HER2-Positive Breast Cancer With Leptomeningeal Disease: A Case Report and Literature Review. | Front Oncol | 2022 | 35251981 | PubTator, text mining | PubMed |
| Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer. | World J Surg Oncol | 2022 | 35249533 | PubTator, text mining | PubMed |
| Interleukin-8: An evolving chemokine. | Cytokine | 2022 | 35247648 | PubTator, text mining | PubMed |
| Reconstruction and analysis of a large-scale binary Ras-effector signaling network. | Cell Commun Signal | 2022 | 35246154 | PubTator, text mining | PubMed |
| Performance modulation through selective, homogenous surface doping of lanthanum strontium ferrite electrodes revealed by in situ PLD impedance measurements. | J Mater Chem A Mater | 2022 | 35223041 | PubTator, text mining | PubMed |
| Investigating oxygen reduction pathways on pristine SOFC cathode surfaces by in situ PLD impedance spectroscopy. | J Mater Chem A Mater | 2022 | 35223039 | PubTator, text mining | PubMed |
| Metabolomics Signature and Potential Application of Serum Polyunsaturated Fatty Acids Metabolism in Patients With Vitiligo. | Front Immunol | 2022 | 35222431 | PubTator, text mining | PubMed |
| Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report. | Clin Kidney J | 2022 | 35211300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2822/papers?page=36